Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents

Furopyrimidines are fused heterocyclic ring systems. Structurally, they are bioisoteres to purines and exerting pharmacological actions in various aspects. They are known to play an important role in different disease conditions. Furo[2,3-d]pyrimidines derivatives have been explored for their inhibi...

Full description

Bibliographic Details
Main Authors: Marwa A. Aziz, Rabah A.T. Serya, Deena S. Lasheen, Khaled A.M. Abouzid
Format: Article
Language:English
Published: SpringerOpen 2016-06-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2314724515300327
_version_ 1818924084047642624
author Marwa A. Aziz
Rabah A.T. Serya
Deena S. Lasheen
Khaled A.M. Abouzid
author_facet Marwa A. Aziz
Rabah A.T. Serya
Deena S. Lasheen
Khaled A.M. Abouzid
author_sort Marwa A. Aziz
collection DOAJ
description Furopyrimidines are fused heterocyclic ring systems. Structurally, they are bioisoteres to purines and exerting pharmacological actions in various aspects. They are known to play an important role in different disease conditions. Furo[2,3-d]pyrimidines derivatives have been explored for their inhibitory activity against different protein kinase enzymes. The present review, to the best of our knowledge, is the first compilation on synthesis, anticancer activity, via inhibition of various protein kinase enzymes, and structure–activity relationships of furo[2,3-d]pyrimidines derivatives reported to date.
first_indexed 2024-12-20T02:19:42Z
format Article
id doaj.art-5b9802a4b24540d9b25615888eb86b2f
institution Directory Open Access Journal
issn 2314-7245
language English
last_indexed 2024-12-20T02:19:42Z
publishDate 2016-06-01
publisher SpringerOpen
record_format Article
series Future Journal of Pharmaceutical Sciences
spelling doaj.art-5b9802a4b24540d9b25615888eb86b2f2022-12-21T19:56:50ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72452016-06-01211810.1016/j.fjps.2015.12.001Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agentsMarwa A. AzizRabah A.T. SeryaDeena S. LasheenKhaled A.M. AbouzidFuropyrimidines are fused heterocyclic ring systems. Structurally, they are bioisoteres to purines and exerting pharmacological actions in various aspects. They are known to play an important role in different disease conditions. Furo[2,3-d]pyrimidines derivatives have been explored for their inhibitory activity against different protein kinase enzymes. The present review, to the best of our knowledge, is the first compilation on synthesis, anticancer activity, via inhibition of various protein kinase enzymes, and structure–activity relationships of furo[2,3-d]pyrimidines derivatives reported to date.http://www.sciencedirect.com/science/article/pii/S2314724515300327Kinase inhibitorsFuro[2,3-d]pyrimidineSynthetic strategyAnticancer
spellingShingle Marwa A. Aziz
Rabah A.T. Serya
Deena S. Lasheen
Khaled A.M. Abouzid
Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
Future Journal of Pharmaceutical Sciences
Kinase inhibitors
Furo[2,3-d]pyrimidine
Synthetic strategy
Anticancer
title Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
title_full Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
title_fullStr Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
title_full_unstemmed Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
title_short Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
title_sort furo 2 3 d pyrimidine based derivatives as kinase inhibitors and anticancer agents
topic Kinase inhibitors
Furo[2,3-d]pyrimidine
Synthetic strategy
Anticancer
url http://www.sciencedirect.com/science/article/pii/S2314724515300327
work_keys_str_mv AT marwaaaziz furo23dpyrimidinebasedderivativesaskinaseinhibitorsandanticanceragents
AT rabahatserya furo23dpyrimidinebasedderivativesaskinaseinhibitorsandanticanceragents
AT deenaslasheen furo23dpyrimidinebasedderivativesaskinaseinhibitorsandanticanceragents
AT khaledamabouzid furo23dpyrimidinebasedderivativesaskinaseinhibitorsandanticanceragents